Glen Eagle Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-800
Closed -$79.4K 934
2019
Q3
$79.4K Hold
800
0.05% 223
2019
Q2
$74K Hold
800
0.05% 231
2019
Q1
$75.5K Hold
800
0.05% 227
2018
Q4
$51.3K Sell
800
-50
-6% -$3.69K 0.04% 241
2018
Q3
$76.1K Hold
850
0.05% 225
2018
Q2
$67.5K Buy
850
+50
+6% +$4.15K 0.05% 228
2018
Q1
$71.4K Sell
800
-120
-13% -$11.5K 0.06% 217
2017
Q4
$96K Sell
920
-75
-8% -$8.46K 0.08% 199
2017
Q3
$145K Buy
995
+890
+848% +$121K 0.14% 151
2017
Q2
$13.6K Buy
105
+55
+110% +$6.74K 0.01% 353
2017
Q1
$6.22K Buy
+50
New +$5.98K 0.01% 436

Other funds holding CELG

Glen Eagle Advisors's CELG Position: Q4 2019 in Review

Glen Eagle Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 800 shares — an estimated $79.4K sold.

Glen Eagle Advisors first reported a position in CELG in Q1 2017 and held it in 11 quarters. The position peaked at $145K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Glen Eagle Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Glen Eagle Advisors sold 800 Celgene Corp shares in Q4 2019, an estimated $79.4K.
  • Glen Eagle Advisors first reported a position in Celgene Corp in Q1 2017 and held it in 11 quarters.
  • Glen Eagle Advisors's Celgene Corp position peaked at $145K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Glen Eagle Advisors's 13F filing for Q4 2019, filed 13 Aug 2024.